Delivery Order SPE2DB22D1017-SPE2DB25FF8JJ

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,284.32, is a Firm Fixed Price Delivery Order for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 10S. The contract has a period of performance through February 18, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,297.53, is a Firm Fixed Price Delivery Order for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a pharmaceutical product. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award. The company maintains a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,362.14, is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a medical product. The contract has an ultimate completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 10S medical patches to the Defense Logistics Agency (DLA). The $2,454.18 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,530.18, is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 4S, a medical product. The contract has an ultimate completion date of April 2, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 4S, a pharmaceutical product. The contract has a ceiling value of $2,410.20 and a completion date of May 30, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on a firm fixed-price basis. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,047.90 firm-fixed-price delivery order is for the procurement of 24 units of the medication SCOPOLAMINE 1 MG/3 DAY PATCH. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $1,026.39 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 24 SCOPOLAMINE 1 MG/3 DAY PATCH units, with an ultimate completion date of June 24, 2025. This contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 4S. The contract has a ceiling value of $1,419.28 and is structured as a firm-fixed-price delivery order with an ultimate completion date of August 2, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract as a child...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $2,493.88 firm fixed-price delivery order is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a medication used for motion sickness. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF8JJ
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,204.08, is a Firm Fixed Price Delivery Order for 4,567,673,519 units of SCOPOLAMINE 1 MG/3 DAY PATCH 10S. The award has a completion date of March 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside.

Generated 6/29/25, 1:05 AM